We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ARPT:TASEAirport City Ltd Analysis

Data as of 2026-03-17 - not real-time

ILA 5,458.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

ARPT is trading at 5,458 ILA, well under its 20‑day (5,724), 50‑day (5,939) and 200‑day (5,942) moving averages, signaling a bearish price environment. The 14‑day RSI sits at 35.7, edging into oversold territory but not yet a clear reversal signal. MACD is in a bearish configuration with the line below the signal and a negative histogram, reinforcing downward momentum. Volume trend is decreasing, suggesting waning buying interest, while 30‑day volatility is elevated at ~28%, indicating sizable price swings. Meanwhile, the stock’s price‑to‑earnings ratio of 11.4 is well below the industry average of 33, yet the price‑to‑book ratio is an extreme 62.3, and the discounted cash‑flow model caps fair value near 2,023 ILA – a stark contrast to the current market price.
Fundamentally, ARPT delivers strong profitability margins (gross 73%, operating 67%, net 49%) but its balance sheet is strained, with a debt‑to‑equity of 61.8 and negative free cash flow of roughly –97 million ILA. Cash on hand (1.84 billion) cushions liquidity but does not offset the leverage concerns. The company’s modest revenue growth of 3.1% and low ROE (5.7%) limit upside, while the “Extreme Greed” market sentiment (fear‑greed index 81.6) may be inflating the price. Given the technical weakness, valuation disconnect, and financial headwinds, the outlook remains cautious.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 8/10

Key Factors

  • Bearish technical indicators (price below all SMAs, MACD bearish)
  • Price far above DCF fair value
  • Decreasing volume and high volatility

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Strong profit margins but high leverage
  • Valuation gap suggests potential correction
  • Modest revenue growth limiting upside

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Fundamental profitability remains solid
  • Debt burden and negative free cash flow pose risks
  • Long‑term fair value estimate far below current price

Key Metrics & Analysis

Financial Health

Revenue Growth3.10%
Profit Margin48.86%
P/E Ratio11.4
ROE5.72%
ROA2.63%
Debt/Equity61.80
P/B Ratio62.3
Op. Cash FlowILA632.7M
Free Cash FlowILA-97021624
Industry P/E33.1

Technical Analysis

TrendBearish
RSI35.7
SupportILA 5,344.00
ResistanceILA 6,051.00
MA 20ILA 5,724.35
MA 50ILA 5,938.90
MA 200ILA 5,942.08
MACDBearish
VolumeDecreasing
Fear & Greed Index81.59

Valuation

Fair ValueILA 2,023.20
GradeOvervalued
TypeValue

Risk Assessment

Beta0.06
Volatility28.48%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.